Meoral | Syrup | 6 ml | 1 pcs

Per ml of solution containing 50 mg rhubarb extract and 10 mg salicylic acid

This oral solution is indicated in the treatment of acute and chronic inflammations of the mucosas of the mouth and throat (Aphthous ulcer, gingivitis, periodontitis and denture irritation).

Oral preparations

This oral solution exerts an anti-inflammatory action in the cases of inflammatory infections on the mucosa of the mouth or throat. Its analgesic properties allow to rapidly suppressing pains and the sensitivity of the tissue submitted to inflammatory processes. This oral solution allows that, after a short time, mucosa resume their normal physiological functions, without exerting any harmful action on the tissues. It’s use is easy and painless. It is well tolerated by individuals sensitive to iodine.

Adults (including the elderly): To be applied to the inflamed oral mucosa (after removing any dentures) three or four times daily using the brush provided. Avoid rinsing the mouth or eating for 15 minutes after application. Always keep the cap closed immediately after every use.

Children: Not recommended below the age of 12 years

There are no known drug interactions and none well documented.

Hypersensitivity to any of the constituents.

A transient local burning sensation at the site of application occurs very commonly. Temporary discoloration of teeth or oral mucosa has been described commonly following administration of oral solution.

Pregnancy: Animal studies are insufficient with respect to effects on pregnancy and/or embryonal / foetal development. The potential risk for human is unknown. Caution should be exercised when prescribing to pregnant women.

Lactation: Anthranoid glycosides derived from rhubarb may be excreted in breast milk. However, at therapeutic doses of oral solution, it is not known whether these, or salicylic acid are excreted in breast milk. A decision on whether to continue breast feeding or to continue therapy with oral solution should be made taking into account the benefit of breast-feeding to the child and benefit of oral solution therapy to the women.

Each bottle of oral solution should be used by only one person.

Overdose associated with local application is unlikely, although the extent of systemic absorption of salicylic acid and anthranoid derivatives are not known. Systemic overdose following ingestion might lead to abdominal cramping, diarrhoea and possibly salicylism (presenting as hyperventilation, tinnitus, deafness, vasodilation, sweating).